Company intelligence / Profile preview

Valpharma International S.p.A.

Ownership: Private
Employees: ~16
Development stage: Commercial

Overview

Valpharma International specializes in the contract development and manufacturing of modified-release pharmaceuticals with proprietary technology. The company supplies finished dosage forms globally and has a strong R&D focus on improving dosing regimens to enhance efficacy and reduce side effects. Some products are commercialized while others remain under development.

Therapeutic areas: GastroenterologyPsychiatryCardiovascularEndocrinology
Modalities: Small molecules (focus on solid oral dosage forms such as tablets and capsules, including modified release formulations)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Valpharma International S.p.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valpharma International S.p.A..

Explore the full profile